Black Diamond Therapeutics Inc (OQ:BDTX)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BDTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Series C Preferred Stock C - Conversion -1,422,862  
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Series B Preferred Stock C - Conversion -6,565,290  
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Common Stock P - Open market or private purchase 800,000 $19.00
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Common Stock C - Conversion 471,800  
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Common Stock C - Conversion 2,176,957  
Feb 3/20 Feb 3/20 Flynn James E Indirect Ownership Series C Preferred Stock C - Conversion -1,142,361  
Feb 3/20 Feb 3/20 Flynn James E Indirect Ownership Common Stock P - Open market or private purchase 400,000 $19.00
Feb 3/20 Feb 3/20 Flynn James E Indirect Ownership Common Stock C - Conversion 378,790  
Feb 5/20 Feb 3/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Series C Preferred Stock C - Conversion -1,713,541  
Feb 5/20 Feb 3/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Common Stock C - Conversion 568,185  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BDTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Series C Preferred Stock C - Conversion -1,422,862  
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Series B Preferred Stock C - Conversion -6,565,290  
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Common Stock P - Open market or private purchase 800,000 $19.00
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Common Stock C - Conversion 471,800  
Feb 5/20 Feb 3/20 Behbahani Ali Indirect Ownership Common Stock C - Conversion 2,176,957  
Feb 5/20 Feb 3/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Series C Preferred Stock C - Conversion -1,713,541  
Feb 5/20 Feb 3/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Common Stock C - Conversion 568,185  
Feb 5/20 Feb 3/20 Versant Venture Capital VI, L.P. Indirect Ownership Common Stock C - Conversion 350,141  
Feb 5/20 Feb 3/20 Versant Venture Capital VI, L.P. Indirect Ownership Common Stock C - Conversion 104,407  
Feb 5/20 Feb 3/20 Versant Venture Capital VI, L.P. Direct Ownership Common Stock C - Conversion 454,548  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BDTX